These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12368147

  • 1. [Simple and rapid determination of leucine by HPLC. Importance for extra-renal treatment of maple syrup urine disease].
    Garcia J, Galinier A, Periquet B, Broué P, Decramer S, Thouvenot JP, Caspar-Bauguil S.
    Ann Biol Clin (Paris); 2002; 60(5):602-6. PubMed ID: 12368147
    [No Abstract] [Full Text] [Related]

  • 2. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R, Srisomsap C, Wasant P, Svasti J, Suthatvoravut U, Chokchaichamnankit D, Liammongkolkul S.
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [Abstract] [Full Text] [Related]

  • 3. [Maple syrup urine disease and cystathioninemia].
    Simma B, Sperl W, Berger H.
    Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
    [Abstract] [Full Text] [Related]

  • 4. Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease.
    Schuchmann L, Witt I, Schulz P, Schumacher H, Rüdiger H.
    Helv Paediatr Acta; 1972 Sep; 27(4):449-56. PubMed ID: 4644280
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM, Rezvani I, Garibaldi LR, Schwartz M.
    N Engl J Med; 1982 Dec 09; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract] [Full Text] [Related]

  • 8. Maple syrup urine disease: emergency treatment of the neonate.
    Hammersen G, Wille L, Schmidt H, Lutz P, Bickel H.
    Monogr Hum Genet; 1978 Dec 09; 9():84-9. PubMed ID: 104150
    [No Abstract] [Full Text] [Related]

  • 9. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P, Jugie M, Rabier D, Desgrès J, Hubert P, Saudubray JM, Man NK.
    Intensive Care Med; 2001 Nov 09; 27(11):1798-806. PubMed ID: 11810125
    [Abstract] [Full Text] [Related]

  • 10. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
    Allen RJ, Frey HJ, Fleming LM, Owings CL.
    Clin Chem; 1972 May 09; 18(5):413-6. PubMed ID: 5019114
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Outcome of early and long-term management of classical maple syrup urine disease.
    Clow CL, Reade TM, Scriver CR.
    Pediatrics; 1981 Dec 09; 68(6):856-62. PubMed ID: 6798541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Maple syrup urine disease. Two cases in Israel.
    Chemke J, Levin S.
    Isr J Med Sci; 1975 Aug 09; 11(8):809-16. PubMed ID: 1165176
    [Abstract] [Full Text] [Related]

  • 18. Maple syrup urine disease: report of a case.
    Rao GP, Ramanamurthy PS, Ghafoorunnisa, Rafeeq MR, Pathak R.
    Indian Pediatr; 1974 Aug 09; 11(8):585-7. PubMed ID: 4443061
    [No Abstract] [Full Text] [Related]

  • 19. Kinetic modeling of plasma leucine levels during continuous venovenous extracorporeal removal therapy in neonates with maple syrup urine disease.
    Jouvet P, Hubert P, Saudubray JM, Rabier D, Man NK.
    Pediatr Res; 2005 Aug 09; 58(2):278-82. PubMed ID: 16085796
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.